We are live on ! Find out more

20 hedge funds and large institutions have $2.18M invested in Myomo in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

34% more capital invested

Capital invested by funds: $1.63M → $2.18M (+$557K)

18% more funds holding

Funds holding: 1720 (+3)

0.06% more ownership

Funds ownership: 0.14%0.2% (+0.06%)

Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
9
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

MYO Hedge Fund Activity: Q1 2018 in Review

20 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Myomo (MYO) for Q1 2018, worth a combined $2.18M — up 34% from $1.63M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MYO positions and 2 closed out — a net gain of 3 holders — while 9 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $379K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $294K sold.

  • 20 institutional investors held Myomo (MYO) as of Q1 2018, up from 17 in Q4 2017.
  • Funds reported $2.18M of Myomo stock for Q1 2018, up 34% quarter-over-quarter.
  • 5 funds opened new Myomo positions in Q1 2018 and 2 closed out, a net change of +3 holders.
  • The largest Myomo buyer in Q1 2018 was Vanguard Group, an estimated $379K added.
  • The largest Myomo seller in Q1 2018 was Hudson Bay Capital Management, an estimated $294K sold.

Based on aggregated 13F filings for Q1 2018.